Albert Esteve Cruella

ISDIN SA engages in the manufacture and development of skin care products. It offers moisturizers, anti-aging, sun protection, ampules and serums, eye treatments, foundation, cleansers, body care, hair thinning products, and brittle nails. The company was founded in 1975 and is headquartered in Barcelona, Spain.

Esteve Huayi Pharmaceutical Co., Ltd. develops, manufactures and commercializes active pharmaceutical ingredients. It also provides opportunities for custom synthesis and toll manufacture projects. The company was founded in 2005 and is headquartered in Shaoxing, China.

Esteve Química SA engages in developing, manufacturing, and marketing of oral and injectable non-sterile active pharmaceutical ingredients for the healthcare industry. Its portfolio includes new chemical entities and generics products such as Bosetan, Pregablin, Duloxetine, and Imatinib. The company was founded in 1966 and is headquartered in Barcelona, Spain.

Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain.

Pensa Investments SL engages in the manufacture of pharmaceutical facilities. The firm specializes in the research, production, development, storage, lease, commercialization, and sale of raw materials and property. The company was founded on December 20, 2019 and is headquartered in Martorelles, Spain.

Corporación Químico Farmacéutica Esteve SA is a pharmaceutical company based in Barcelona, ES. and has subsidiaries in the Europe and Americas regions. Esteve manufactures and distributes pharmaceutical products. The Spanish company was founded in 1986 and the CEO is Staffan Schüberg.

Esteve Healthcare SL is a Spanish international specialty pharma company that has experienced significant growth in 2022, expanding its presence in Europe and beyond. Esteve Healthcare is based in Barcelona, ES, and has subsidiaries in Germany. The company has launched an inhaled treatment for off periods in Parkinson's disease and is collaborating with Medtronic to improve the pathway of patients with refractory cancer pain. The company was founded in 1929 by Antoni Esteve Subirana, and Staffan Schüberg has been the CEO of the company since 2019.

Hangzhou Jiuyuan Gene Engineering Co. Ltd. operates as a biopharmaceutical company. It specializes in R&D, manufacturing and commercialization of biopharmaceutical products and medical devices. Hangzhou Jiuyuan therapeutic includes orthopedics, metabolic diseases, oncology, and hematology services. The company was founded on December 31, 1993 and is headquartered in Hangzhou, China.